<DOC>
	<DOCNO>NCT02731534</DOCNO>
	<brief_summary>The purpose study confirm non-inferiority Z-213 compare Saccharated Ferric Oxide use maximum change Hb baseline 12 week patient Iron-deficiency Anemia ( IDA )</brief_summary>
	<brief_title>Efficacy Study Intravenous Iron Preparation Iron Deficiency Anemia</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<mesh_term>Deficiency Diseases</mesh_term>
	<mesh_term>Ferric oxide , saccharated</mesh_term>
	<mesh_term>Ferric Compounds</mesh_term>
	<criteria>Patients iron deficiency anemia Patients anemia cause condition iron deficiency Patients abnormal laboratory test value screen Serum phosphorus , Aspartate aminotransferase , Alanine aminotransferase Patients liver , kidney circulatory system disease Patients history present illness malignant tumor autoimmune disease Patients underwent intravenous administration iron preparation , administration erythropoiesis stimulation agent blood transfusion within 8 week screen Patients underwent oral administration iron preparation ( include overthecounter drug supplement ) within 4 week screen</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>